Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.
Oztürk MA, Barişta I, Altundağ MK, Türker A, Yalçin S, Celik I, Güllü I, Güler N, Ozişik Y, Kars A, Kansu E, Baltali E, Tekuzman G. Oztürk MA, et al. Among authors: yalcin s. Chemotherapy. 2002 Dec;48(5):252-8. doi: 10.1159/000066768. Chemotherapy. 2002. PMID: 12476042 Clinical Trial.
Leptomeningeal infiltration of malignant mesothelioma.
Oksüzoğlu B, Yalçin S, Erman M, Dağdelen S. Oksüzoğlu B, et al. Among authors: yalcin s. Med Oncol. 2002;19(3):167-9. doi: 10.1385/MO:19:3:167. Med Oncol. 2002. PMID: 12482127
Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Altundag O, Gullu I, Altundag K, Yalcin S, Ozyar E, Cengiz M, Akyol F, Yucel T, Hosal S, Sozeri B. Altundag O, et al. Among authors: yalcin s. Head Neck. 2005 Jan;27(1):15-21. doi: 10.1002/hed.20107. Head Neck. 2005. PMID: 15515158 Clinical Trial.
Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial.
Ocvirk J, Brodowicz T, Wrba F, Ciuleanu TE, Kurteva G, Beslija S, Koza I, Pápai Z, Messinger D, Yilmaz U, Faluhelyi Z, Yalcin S, Papamichael D, Wenczl M, Mrsic-Krmpotic Z, Shacham-Shmueli E, Vrbanec D, Esser R, Scheithauer W, Zielinski CC. Ocvirk J, et al. Among authors: yalcin s. World J Gastroenterol. 2010 Jul 7;16(25):3133-43. doi: 10.3748/wjg.v16.i25.3133. World J Gastroenterol. 2010. PMID: 20593498 Free PMC article. Clinical Trial.
1,148 results